Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NRIX · against 1,336 other Healthcare companies
Ranked #329 of 1,337 · scores higher than 75% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 70–79, including NRIX · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | NRIX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -13.4% | 1.5% | 17% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -15.4% | 4.2% | 13% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -11.4% | -1.0% | 24% | 20% | |
| Book yieldHigher is better · 1,306 reported | 15.0% | 37.9% | 21% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 329 | 38.9B USD | 75 | 56 | |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 329 |
| 655M AUD (≈$432M) |
| 75 |
| 62 |
| 329 | 1.8B USD | 75 | 80 |
| 329 | 107M USD | 75 | 31 |
| 329 | 2.7B USD | 75 | 84 |
| 329 | 540M ILS (≈$146M) | 75 | 49 |
| 329 | 464M USD | 75 | 53 |
| 329 | 646M USD | 75 | 46 |
| 329 | 1.2B USD | 75 |